SUBSCRIBE
SUBSCRIBE

Brandon May

Courtesy of Getty Images
Drug Development
Lilly’s Tirzepatide Significantly Reduces A1C, Body Weight Versus Insulin Glargine
Eli Lilly’s SURPASS-4 trial program shows tirzepatide, significantly reduced blood glucose levels and body weight better than insulin glargine in adult patients with type 2 diabetes.
May 20, 2021
 · 
3 min read
 · 
Brandon May
Drug Development
FDA Receives Slew of New Drug Applications for Bipolar Disorder, Opioid Disorder and Rare Disease
Several biopharmaceutical companies have submitted NDAs to the U.S. FDA covering treatment indications ranging from an opioid overdose, bipolar disorder and rare disease.
May 19, 2021
 · 
2 min read
 · 
Brandon May
Michael Vi/Getty Images
FDA
Iovance Biotherapeutics Faces Another Delay in BLA Submission for TIL Therapy
The FDA further delays Iovance’s filing for its TIL therapy as it requests additional data on the treatment’s potency assays.
May 19, 2021
 · 
2 min read
 · 
Brandon May
Business
New Study Identifies Brain Proteins Predictive of Future Dementia
A new study from Johns Hopkins University Bloomberg School of Public Health suggests the development of dementia is associated with abnormal levels of plasma proteins, and these proteins may be predictive of dementia up to five years before a patient receives a diagnosis.
May 18, 2021
 · 
3 min read
 · 
Brandon May
Business
Tamasek-Backed G2 Bio Companies Will Accelerate Gene Transfer Technologies
Temasek has committed $200 million to launch The G2 Bio Companies which focuses on the development of potential next-generation gene therapies.
May 18, 2021
 · 
2 min read
 · 
Brandon May
Eyesonmilan / Shutterstock
Drug Development
Incyte’s Ruxolitinib Cream Shows Promise for Vitiligo in Phase III Trials
The use of ruxolitinib cream, Incyte’s investigational anti-inflammatory JAK inhibitor topical treatment, significantly improved facial vitiligo in adolescents and adults.
May 17, 2021
 · 
3 min read
 · 
Brandon May
Pictured: Regeneron logo on a light brown building
Drug Development
Regeneron’s Evinacumab Reduces High Triglycerides but Stumbles in Genetic Subgroup
A recent Phase II trial show Regeneron’s monoclonal antibody evinacumab significantly reduced fasting triglycerides in patients with severe hypertriglyceridemia.
May 17, 2021
 · 
3 min read
 · 
Brandon May
Business
Report Highlights “Disinformation Dozen” Responsible for Online COVID-19 Vaccine Misinformation
Overall, the researchers claim this “Disinformation Dozen” generate approximately 65% of the anti-vaccine misinformation on these platforms.
May 14, 2021
 · 
3 min read
 · 
Brandon May
Drug Development
Interline Will Focus $92 Million Investment to Advance Precision Medicine Platform
Foresite Labs-incubated company Interline Therapeutics announced Thursday that it had raised $92 million in a financing round co-led by Foresite Capital and ARCH Venture Partners.
May 14, 2021
 · 
2 min read
 · 
Brandon May
Drug Development
Monoclonal Antibody Proves Worth in Asthma Study
Pivotal data from Amgen’s and AstraZeneca’s NAVIGATOR Phase III trial show tezepelumab, a potential first-in-class human monoclonal antibody, reduced asthma aggravations and exacerbations requiring hospitalizations better than placebo in patients with severe asthma.
May 13, 2021
 · 
3 min read
 · 
Brandon May
Igor Golovniov/SOPA Images/LightRocket via Getty I
Job Trends
Third Rock Ventures Launches Flare Therapeutics With $82 Million Series A
Significant contributions were made to the Series A by Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management.
May 13, 2021
 · 
2 min read
 · 
Brandon May
Business
Study Finds HIV-Containing Gene Therapy Restores Immunity in “Bubble Baby” Disease
Nearly 50 infants with “bubble baby” disease developed a working immune system after they received a gene therapy that contained the AIDS virus, according to a new study.
May 12, 2021
 · 
2 min read
 · 
Brandon May
Paul Hennessy/SOPA Images/LightRocket via Getty Im
Policy
Cities and States Go All Out on Incentives to Encourage COVID-19 Vaccination
In the U.S., many states and organizations are using unique tactics to improve vaccination rates including setting up mobile vans, offering $100 incentives, and free beers.
May 12, 2021
 · 
3 min read
 · 
Brandon May
Pictured: FDA sign at headquarters/Courtesy of Get
Drug Development
FDA Clears Samus Drug for Glioma Phase Ib Study
Clearance of the IND allows Samus to proceed with a Phase Ib trial to assess the safety, tolerability and pharmacokinetics of PU-AD in a small group of patients with recurrent malignant glioma.
May 11, 2021
 · 
2 min read
 · 
Brandon May
Drug Development
Renal-Focused Alebund Pharma Raises $60 Million in Series B Financing Round
Shanghai-based Alebund Pharmaceuticals has raised $60 million in a new Series B financing round that will be harnessed to further drive the company’s focus on renal disease.
May 10, 2021
 · 
2 min read
 · 
Brandon May
Load More